Integrating findings of traditional medicine with modern pharmaceutical research: the potential role of linked open data
- 8.6k Downloads
One of the biggest obstacles to progress in modern pharmaceutical research is the difficulty of integrating all available research findings into effective therapies for humans. Studies of traditionally used pharmacologically active plants and other substances in traditional medicines may be valuable sources of previously unknown compounds with therapeutic actions. However, the integration of findings from traditional medicines can be fraught with difficulties and misunderstandings. This article proposes an approach to use linked open data and Semantic Web technologies to address the heterogeneous data integration problem. The approach is based on our initial experiences with implementing an integrated web of data for a selected use-case, i.e., the identification of plant species used in Chinese medicine that indicate potential antidepressant activities.
KeywordsChinese Medicine Resource Description Framework Aristolochic Acid Semantic Technology PubMed Abstract
Associative tags (snippets of HTML that capture the information in a machine-readable, interlinked format)
Resource description framework
SPARQL Protocol and RDF Query Language
Web Ontology Language
Open Biological and Biomedical Ontologies
traditional Chinese medicine
Ethnopharmacological findings are scattered over a multitude of publications and databases and are not well connected to other biomedical databases. As a result, the utility of these sources as knowledge resources are severely limited, which creates a further obstacle for modern day e-science research, which relies heavily on multiple heterogeneous data sources. Semantic technologies and standards, such as the Resource Description Framework (RDF)  and the Web Ontology Language (OWL)  provide technology that has potential to be used to help tackle the problem . In recent years, relevant databases have been converted their data into the RDF/OWL format. This effort is exemplified by DartGrid, a toolkit for exposing relational datasets in RDF/OWL format . A large-scale e-science infrastructure of datasets and ontologies for Chinese medicine was developed [5, 6, 7]. Unfortunately, the public accessibility to many of these resources is limited. This article proposes an alternate approach, using linked open data and Semantic Web technologies to address the heterogeneous data integration problem.
Semantic Web approach
We investigated the usefulness of openly available RDF/OWL tools and datasets to find evidence for pharmaceutical compounds from Chinese medicine that may treat depressive disorders or serve as lead compounds for the future pharmaceutical drug development. The reasons for choosing a psychological disorder were two-fold. Firstly, the development of traditional medicines such as Chinese medicine was mainly guided by symptomatological and introspective observations without the need for sophisticated experimental methods available only to modern medicine. Mental conditions, such as depression, are amenable to these kinds of phenomenological observations. It is possible to use traditional medicines to identify the source of pharmacological compounds that may otherwise be missed by modern rational drug design. Secondly, the conceptualization of mental conditions is diverse across different eras and different cultures. For example, there seems to be no one-to-one equivalent to the concept of 'depressive disorder' in Chinese medicine. Instead, the symptoms of depression  match the symptoms associated with several major Chinese medicine classifications (Table 1) . The use of semantic technologies may help bridge these gaps by making the meaning and interrelations of various concepts more explicit and facilitating the integration of heterogeneous data sources.
Chinese medicine categories with potential relevance for depressive disorders (adapted from 9)
Examples of representative plants
palpitations, anxiety, insomnia
Zizyphus spinosa Hu, Platycladus orientalis Franco, Albizia julibrissin Durazz.
lethargy, weakness, poor appetite, weak voice, pale complexion, breathlessness, immunodeficiency
Panax ginseng C. A. Mey, Codonopsis pilosula Nannf., Astragalus propinquus Schischkin, Atractylodes Koidz., Glycyrrhiza spp., Dioscorea opposita Thunb.
systemic exhaustion, fear of cold, cold extremities, withdrawal, sore and weak lower back, slow and deep pulse
Cistanche deserticola Ma, Epimedium grandiflorum Morr, Psoralea corylifolia L., Alpinia oxyphylla Miq., Eucommia ulmoides Oliver, Dipsacus asper Wall, Morinda citrifolia L., Cnidium monnieri L.
delirium, seizure, coma, various psychiatric conditions (such as bipolar depression)
Polygala tenuifolia Willdenow, Liquidambar orientalis Miller, Acorus gramineus Sol.
The use of semantic annotations added practical value to the manually curated dataset we produced. Recently, TCMGeneDIT , a database of facts extracted from literature indicating associations between Chinese medicines, genes, diseases, effects and ingredients, was converted to RDF [16, 17]. Since the RDF version of TCMGeneDIT contains a mapping to DBpedia, the manually curated aTags and the TCMGeneDIT dataset are semantically interlinked through their shared DBpedia identifiers, thereby demonstrating the potential of linked data technologies.
In addition to the data from traditional medicines, we generated aTags about pharmacogenomic findings associated with approved antidepressant pharmaceuticals  in order to relate and compare between traditional medicines and approved pharmaceuticals. The aTags were generated from known associations between gene variants, side effects and outcomes arising from drug treatments of depression. Relevant articles were initially identified by curators at the PharmGKB database  to identify articles about a pharmacogenomic association in the treatment of depression. Gene variants, side effects and clinical outcomes were curated from a subset of these articles and added to an ontology-driven knowledge base that extended the PharmGKB data in RDF format.
Preliminary results and evaluation
We identified several plant species whose potential antidepressant action was recorded in the Chinese medicine literature. The following text focuses on Polygala tenuifolia, Magnolia officinalis and Albizia julibrissin,three medicinal plants currently not known to possess activities related to the central nervous system.
Relevant information in RDF/OWL resources
A search using Sindice  revealed no useful RDF/OWL data about these three plants apart from the manually curated data created by the authors of this article and the general information provided by DBPedia. Targeted queries in the linked data representations  of DrugBank [24, 25] and Clinicaltrials.gov  found no information about the medical use of these three plants. They have not been tested in a controlled clinical trial.
We found the RDF version of TCMGeneDIT to contain data for two of the three plants, namely Polygala tenuifolia and Magnolia officinalis. Since the RDF version of TCMGeneDIT contains a map to DBpedia, the manually curated aTags and the TCMGeneDIT dataset are semantically interoperable through shared DBpedia identifiers.
Examples of relevant pharmacological findings
Below we list examples of relevant pharmacological findings for each plant captured in the RDF/OWL resources we investigated.
Polygala tenuifolia (DBpedia identifier 'http://dbpedia.org/resource/Polygala_tenuifolia') is one of the 50 'fundamental herbs' used in Chinese medicine. Used for conditions such as delirium, seizure, coma and various psychiatric conditions, Polygala tenuifolia is associated with the 'Phlegm (Heart)' category in traditional Chinese medicine (TCM). According to DBpedia, however, it is mainly used as an expectorant. The RDF version of TCMGeneDIT contains several references for treatment effects, namely 'antipsychotic', 'cholinergic', 'therapeutic' and, seemingly contradictive, both 'antiinflamatory' and 'inflammatory'. References to antidepressant activity are lacking in TCMGeneDIT (and this is true for all of the plants presented here). The manually curated aTag dataset contains several curated statements from PubMed abstracts that clearly indicate an antidepressant action of Polygala tenuifolia and indicate that 3,6'-disinapoyl sucrose is the main compound responsible for these effects. These data suggest several interesting mechanisms of action behind these antidepressant effects, namely reduction of stress hormone levels, upregulation of neurotrophic factors and increased neuronal plasticity and neurogenesis [27, 28].
Magnolia officinalis (DBpedia identifier 'http://dbpedia.org/resource/Magnolia_officinalis') is a widely known ornamental tree with a long history of medical use. The manually curated aTags about Magnolia officinalis point to several publications describing anxiolytic and antidepressant effects of Magnolia officinalis extracts [29, 30]. Some potential mechanisms of action recorded in the curated dataset are modulation of GABA and adenosine receptors  as well as neurotrophic activity . The main active ingredients responsible for these effects are Honokiol, Magnolol and related compounds.
The bark and flowers of Albizia julibrissin (DBpedia identifier 'http://dbpedia.org/resource/Albizia_julibrissin') are used in Chinese medicine. Associated with symptoms such as palpitations, anxiety and insomnia, Albizia julibrissin is classified under the 'Shen (Mind)' category in TCM. A potential mechanism of action described in the literature is the general modulation of the serotonin system, especially modulation of 5-HT1 receptors. The connection between 5-HT1 receptors and antidepressant response was also found in aTags extracted from PubMed conclusion sections.
How helpful are currently available semantic resources?
Several plants showing promising neurochemical and behavioral effects were identified and further characterized with semantic technologies. Most of these plants are obscure to the medical community outside Chinese medicine.
For researchers without a strong background in Chinese medicine, the categorization of diseases, symptoms and indications according to Chinese medicine theory can be misleading and confusing. For example, Polygala tenuifolia, one of the most promising plants with potential antidepressant activities according to PubMed abstracts, is found in the 'Phlegm (Heart)' category. Furthermore, the placement in a certain Chinese medicine category did not appear to be a reliable predictor of pharmacological activities in PubMed abstracts. This situation may be improved by a mapping between Chinese medicine classes and associated scientific categorizations of diseases, symptoms and indications, possibly formalized as an OWL ontology.
Increased reliance on well-structured consensus taxonomies with explicit semantics not only facilitates pharmacological research, but also helps prevent serious harm to patients by decreasing the probability of misunderstandings and errors in the formulation and prescription of herbal remedies. For instance, over a hundred cases of severe renal failure caused by aristolochic acids were reported in Europe  as a result of herbal mixtures erroneously containing the poisonous plant Aristolochia fangchi. The reason for this error was that some plant species from different regions of China have very similar names. For example, Fangji refers to two different plants, Stephania tetrandra (Hanfangji), which is the correct ingredient for the herbal mixture, and Aristolochia fangchi (Guangfangji), which contains highly nephrotoxic and carcinogenic aristolochic acids. A simple taxonomy or ontology of these pharmaceutical ingredients may help reduce such human errors.
While potential antidepressant activities are clearly described in literature, the TCMGeneDIT database and its RDF representation did not contain such data, underlining the well-known fact that the automated extraction of structured data from biomedical texts cannot be achieved with perfect recall and that manual curation is still a necessity to turn unstructured biomedical literature into structured data.
As expected, the manual curation of scientific statements in literature proved to be a time-consuming process, but manual curation is in many cases indispensable due to the limited availability of structured databases. While several databases for Chinese medicine exist , they are not publicly available and thus could not be integrated into the interlinked data structure we created. The unified Chinese medical language system UTCMLS , a large ontology/taxonomy for Chinese medicine, was not publicly available at the time of preparing this manuscript. It would be a significant gain for the research community if these databases were made publicly accessible.
RDF stores have been known to have performance issues, however, both performance and reliability of RDF stores has steadily improved in the past few years and they are now capable of handling very large biomedical datasets.
There are several potential advantages of linked data technologies and ontologies compared to classical technologies (e.g., non-semantic web pages, SQL databases, specialized REST and SOAP application interfaces). For example, it is now possible to create a decentralized network of diverse datasets that can be transparently queried through open web standards. Basic, machine and human-readable information about each entity can be retrieved through a simple HTTP GET request, thereby improving the transparency of large distributed datasets. The RDF/OWL standards can be used in multilingual environments. Powerful mechanisms for ontology-based alignment of data sources are also available.
However, user-friendly software applications based on linked data standards are still lacking. While there are several specialized and user-friendly interfaces for accessing certain linked datasets, such as a dedicated interface for aTags and a dedicated interface for the TCMGeneDIT data, there is a lack of good user interfaces for the exploration of aggregated and heterogeneous datasets. In our prototypical scenario, currently available, generic linked data browsers such as Marbles  or Sig.ma  did not produce a satisfactory user experience for ordinary pharmaceutical researchers. The linked data community must invest more resources in the creation of applications geared towards end-users. The creation of such applications may be simplified if linked data providers reuse existing upper ontologies and schemas, such as those offered by the Open Biological and Biomedical Ontologies (OBO) project .
This article presents only the initial steps on a 'bridge' linking traditional medicines and modern pharmaceutical research. More of the existing databases about traditional medicines must be made publicly accessible and interlinked for broader integration. Semantic technologies and linked data provide a solid foundation for building such an integrated data infrastructure.
We would like to thank all participants of the W3C Semantic Web for Health Care and Life Science Interest Group. Thanks to Bob Powers for implementing a prototypical script for generating aTags from online content. The work of MS was funded by the Science Foundation Ireland under Grant No. SFI/08/CE/I1380 (Lion-2). The work of JZ is funded by a EPSRC grant (EP/G049327/1). The work of JSL and Bob Powers was funded by Predictive Medicine, Inc., Belmont, MA, USA.
- 1.RDF Primer. [http://www.w3.org/TR/rdf-primer/].
- 2.OWL Web Ontology Language Overview. [http://www.w3.org/TR/owl-features/].
- 4.Chen H, Wang Y, Wang H, Mao Y, Tang J, Zhou C, Yin A, Wu Z: Towards a Semantic Web of relational databases: A practical Semantic toolkit and an In-Use Case from traditional Chinese medicine. Proceedings of 5th International Semantic Web Conference ISWC 2006, November 5-9, 2006. 2006, Berlin: Springer Athens, 750-763.Google Scholar
- 8.American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. Washington DC. 2000.Google Scholar
- 10.aTags about ethnopharmacological findings. [http://hcls.deri.org/atag/data/tcm_atags.html].
- 11.Auer S, Bizer C, Kobilarov G, Lehmann S, Cyganiak R, Iveset Z: DBpedia: a nucleus for a Web of Open Data. The Semantic Web, 6th International Semantic Web Conference, 2nd Asian Semantic Web Conference, ISWC 2007 + ASWC 2007, Busan, Korea, November 11-15, 2007. Edited by: Aberer K. 2008, Springer, 722-735.Google Scholar
- 13.RDFa Primer. [http://www.w3.org/TR/xhtml-rdfa-primer/].
- 14.PubMed home. [http://www.ncbi.nlm.nih.gov/pubmed/].
- 17.Zhao J, Jentzsch A, Samwald M, Cheung K: Linked Data for connecting traditional Chinese medicine and Western medicine. Poster & Poster/Demo Abstract Proceedings Data Integration in the Life Sciences: 20-22 July 2009; Manchester. 2009, 13:Google Scholar
- 18.HCLSIG BioRDF Subgroup/aTags/datasets - ESW Wiki. [http://esw.w3.org/topic/HCLSIG_BioRDF_Subgroup/aTags/datasets].
- 20.aTag Explorer. [http://hcls.deri.org/atag/explorer/].
- 21.HCLSIG BioRDF Subgroup/DERI HCLS KB - ESW Wiki. [http://esw.w3.org/topic/HCLSIG_BioRDF_Subgroup/DERI_HCLS_KB].
- 22.Sindice - The semantic web index. [http://sindice.com/].
- 23.Jentzsch A, Zhao J, Hassanzadeh O, Cheung KH, Samwald M, Andersson B: Linking Open Drug Data. Proceedings of the Second Triplification Challenge 2009, Graz, Austria. 2009Google Scholar
- 25.DrugBank: Home. [http://drugbank.ca/].
- 26.Home - ClinicalTrials.gov. [http://www.clinicaltrials.gov/].
- 35.Marbles Linked Data Engine. [http://marbles.sourceforge.net/].
- 36.sig.ma - Semantic Information MAshup. [http://sig.ma/].
- 37.Open Biological and Biomedical Ontologies. [http://obofoundry.org/].
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.